Biotage AB (publ) (STO:BIOT)

Market Cap	7.24B
Revenue (ttm)	2.06B
Net Income (ttm)	284.00M
Shares Out	80.05M
EPS (ttm)	3.55
PE Ratio	25.47
Forward PE	30.49
Dividend	1.65 (1.89%)
Ex-Dividend Date	Apr 25, 2025

Volume	124,939
Average Volume	232,483
Open	90.50
Previous Close	90.40
Day's Range	89.95 - 91.70
52-Week Range	81.60 - 202.20
Beta	0.84
RSI	38.52
Earnings Date	Apr 3, 2025

About Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, parallel peptide purification, and work-up products; flash systems and accessories, and normal and reversed phase cartridges; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal and supported scavengers and reagents, as well as accessories and spare parts...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1969
• Employees: 680
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BIOT

Financial Performance

In 2024, Biotage AB's revenue was 2.06 billion, an increase of 10.42% compared to the previous year's 1.86 billion. Earnings were 284.00 million, an increase of 15.45%.